2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH DENA BATTLE
Patient Perspectives on Cytoreductive Nephrectomy after the CARMENA Trial

VIEW ALL ASCO GU 2019 VIDEOS

Prostate Cancer Foundation 2018 Scientific Retreat

Prostate Cancer Foundation 2018 Scientific Retreat

INTERVIEW WITH OLIVER SARTOR
Overall Survival Benefit and Racial Disparities in African American Men with Metastatic Prostate Cancer

VIEW ALL PCF VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH KARIM FIZAZI
ARAMIS - Efficacy and Safety of Darolutamide in nmCRPC

VIEW ALL ASCO GU 2019 VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH JAMES GULLEY
Immunotherapy Across Genitourinary Malignancies

VIEW ALL ASCO GU 2019 VIDEOS

Featured Videos

#AUA14 - Session Highlights: Contemporary minimally invasive management of adrenal disorders: An international multi-institutional survey

ORLANDO, FL USA (UroToday.com) - Many new minimally invasive approaches to adrenalectomy have emerged in the last 20 years to complement conventional laparoscopy, including robotics, mini-laparoscopy, and laparoendoscopic single-site (LESS) surgery. Dr. Hak Lee presented a study during this session which examined trends in minimally invasive surgery (MIS) in adrenalectomy, internationally, over the past 5 years.

auaIn this multi-institutional study including 18 academic centers in Europe, Asia, South America, and the U.S., a total of 867 adrenalectomies were examined. Overall the most common surgical approach utilized across the institutions remained conventional laparascopy (55%), with LESS surgery the second most common (30%). The majority of LESS cases in the series were performed in Asia (82%) while the vast majority of mini-laparoscopy cases were performed in Europe centers (96%). No difference was seen between the four MIS approaches with regards to major complications (greater than or equal to Clavien grade IIIa), transfusion rate or 30-day readmission rate. The absolute number of adrenalectomies being performed over the last 5 years by the institutions included in the study increased annually.

The authors found that multiport laparoscopy use decreased from 100% of the MIS adrenalectomies in 2008 to just 47% in 2013 in the study institutions. In contrast utilization of LESS surgery increased the fastest at 6.5% per year. Robotic (1.5%/year) and mini-laparoscopic (2.2%/year) approaches experienced much slower growth rates in comparison. With similar surgical outcomes as demonstrated by the study, one must assume that the demonstrated regional differences in utilization of the different MIS approaches must depend upon the availability of the technology necessary, as well as surgeon training and preference.

Presented by Hak J. Lee, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

San Diego, CA USA

Written by Timothy Ito, MD, medical writer for UroToday.com

AUA 2014, #AUA14, laparo-endoscopic single-site (LESS), minimally invasive surgery (MIS), adrenalectomy

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 3 Issue 4

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe